ArticleWorld journal of gastrointestinal oncology2024
Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma?
Natalia Centrone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.